PMID- 19823802 OWN - NLM STAT- MEDLINE DCOM- 20100423 LR - 20220309 IS - 1432-0428 (Electronic) IS - 0012-186X (Linking) VI - 52 IP - 12 DP - 2009 Dec TI - Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. PG - 2633-41 LID - 10.1007/s00125-009-1548-8 [doi] AB - AIMS/HYPOTHESIS: Interphotoreceptor retinoid-binding protein (IRBP) plays a major role in the visual cycle and is essential to the maintenance of photoreceptors. The aim of this study was to determine whether a decrease in IRBP production exists in the early stages of diabetic retinopathy. METHODS: Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot. Human post mortem eyes (n = 16) from diabetic donors without clinically detectable retinopathy and from non-diabetic donors (n = 16) were used to determine IRBP (also known as RBP3) mRNA levels (RT-PCR) and protein content (western blot and confocal microscopy). Retinal neurodegeneration was assessed by measuring glial fibrillar acidic protein (GFAP) and the apoptotic rate. Y79 human retinoblastoma cells were used to test the effects of glucose, TNF-alpha and IL-1beta on IRBP expression and IRBP levels. RESULTS: Intravitreous IRBP concentration was significantly lower in PDR < NPDR < control in proteomic and western blot analysis. IRBP mRNA levels and IRBP protein content were significantly lower in the retinas from diabetic donors than in those from non-diabetic donors. Increased GFAP and a higher degree of apoptosis were observed in diabetic retinas compared with non-diabetic retinas. A dose-dependent downregulation of IRBP mRNA expression and IRBP content was detected with glucose, TNF-alpha and IL-1beta in cultures of Y79 human retinoblastoma cells. CONCLUSIONS/INTERPRETATION: Underproduction of IRBP is an early event in the human diabetic retina and is associated with retinal neurodegeneration. The mechanisms leading to this deficit deserve further investigation. FAU - Garcia-Ramirez, M AU - Garcia-Ramirez M AD - CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM), Diabetes and Metabolism Research Unit, Institut de Recerca Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain. FAU - Hernandez, C AU - Hernandez C FAU - Villarroel, M AU - Villarroel M FAU - Canals, F AU - Canals F FAU - Alonso, M A AU - Alonso MA FAU - Fortuny, R AU - Fortuny R FAU - Masmiquel, L AU - Masmiquel L FAU - Navarro, A AU - Navarro A FAU - Garcia-Arumi, J AU - Garcia-Arumi J FAU - Simo, R AU - Simo R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091013 PL - Germany TA - Diabetologia JT - Diabetologia JID - 0006777 RN - 0 (Eye Proteins) RN - 0 (Glial Fibrillary Acidic Protein) RN - 0 (RNA, Messenger) RN - 0 (Retinol-Binding Proteins) RN - 0 (interstitial retinol-binding protein) SB - IM MH - Age of Onset MH - Aged MH - Apoptosis MH - Diabetic Retinopathy/*genetics/metabolism/pathology MH - Down-Regulation MH - Eye Proteins/*genetics/metabolism MH - Female MH - Gene Amplification MH - Genes, Retinoblastoma/genetics MH - Glial Fibrillary Acidic Protein/metabolism MH - Humans MH - Male MH - Microscopy, Confocal/methods MH - Middle Aged MH - Photoreceptor Cells, Vertebrate/*metabolism MH - RNA, Messenger/genetics MH - Retinal Neoplasms/genetics/pathology MH - Retinal Perforations/genetics/metabolism/pathology MH - Retinoblastoma/genetics/pathology MH - Retinol-Binding Proteins/*genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Vitreous Body/metabolism EDAT- 2009/10/14 06:00 MHDA- 2010/04/24 06:00 CRDT- 2009/10/14 06:00 PHST- 2009/07/27 00:00 [received] PHST- 2009/09/02 00:00 [accepted] PHST- 2009/10/14 06:00 [entrez] PHST- 2009/10/14 06:00 [pubmed] PHST- 2010/04/24 06:00 [medline] AID - 10.1007/s00125-009-1548-8 [doi] PST - ppublish SO - Diabetologia. 2009 Dec;52(12):2633-41. doi: 10.1007/s00125-009-1548-8. Epub 2009 Oct 13.